LifeVantage Corporation (LFVN) Stock Forecast
LFVN analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 2 analysts
- Price target
- $7.50 average of analyst targets
- Upside to target
- +25.0% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $0.03
- 52-week range
- $4.02 – $10.70
LFVN analyst ratings
2 analystsNumber of analysts at each rating.
LFVN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
LFVN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.06 | $0.03 | $0.10 | $0.18 | −64.8% | 3 |
| Next quarter (Dec '26) | $0.08 | $0.06 | $0.11 | $0.15 | −46.7% | 3 |
| Current fiscal year (FY2027) | $0.32 | $0.18 | $0.40 | $0.56 | −42.3% | 3 |
| Next fiscal year (FY2028) | $0.39 | $0.21 | $0.53 | $0.32 | +19.6% | 3 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
LFVN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $40.5M | $38.6M | $41.9M | −14.9% | 3 |
| Next quarter (Dec '26) | $41.7M | $39.7M | $44.0M | −14.9% | 3 |
| Current fiscal year (FY2027) | $165.5M | $160.8M | $171.6M | −9.4% | 3 |
| Next fiscal year (FY2028) | $167.7M | $160.6M | $176.8M | +1.3% | 3 |
LFVN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
LFVN revenue: reported and forecast
LFVN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.10 | $0.10 | $0.10 | $0.10 | $0.06 | −36.7% | 0 up · 1 down |
| Next quarter (Dec '26) | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 0.0% | 0 up · 1 down |
| Current fiscal year (FY2027) | $0.46 | $0.46 | $0.46 | $0.46 | $0.32 | −29.2% | 1 up · 2 down |
| Next fiscal year (FY2028) | $0.41 | $0.41 | $0.41 | $0.41 | $0.39 | −5.7% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
LFVN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; LFVN beat in 6 of 12.
What analysts expect from LFVN
2 analysts cover LifeVantage; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $7.50, 25.0% above the latest close of $6.00. Analysts expect earnings of $0.32 per share for FY2027, −42.3% from a year earlier. For FY2028 the average estimate is $0.39 per share on revenue of $167.7 million. LifeVantage beat the EPS estimate in 6 of the last 12 quarters.
Related: LFVN income statement, LFVN key metrics, LFVN chart. See the LFVN stock overview for the latest quote and news.
LFVN forecast FAQ
What is LifeVantage's price target?
The average analyst price target for LifeVantage is $7.50, 25.0% above the latest close of $6.00.
Is LifeVantage a buy, hold or sell?
Of 2 analysts covering LifeVantage, 1 rate it a strong buy, 0 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is LifeVantage's EPS forecast?
Analysts forecast $0.32 per share for FY2027 (range $0.18 to $0.40); for FY2028 the estimate is $0.39.
What is LifeVantage's revenue forecast?
The average revenue estimate for FY2027 is $165.5 million, growth of −9.4%; for FY2028 it is $167.7 million.
When does LifeVantage report earnings?
LifeVantage is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $0.03.
Does LifeVantage usually beat earnings estimates?
LifeVantage reported EPS at or above the analyst estimate in 6 of the last 12 quarters.